Skip to main content
. 2007 Jan 17;22(1):107–114. doi: 10.1007/s11606-006-0016-0

Table 3.

Randomized controlled trials, stratified by risk of deep venous thrombosis

Author (ref) year subjects Intervention Mean duration air travel Subjects with DVT*/total subjects P Standards met
Control Intervention
Proximal Distal Total Proximal Distal Total
Air travelers without increased DVT risk§
Scurr26 2001 200 Graduated compression stockings 20–30 mmHg at ankle “put on before the start of travel” 16.5 h over 13–32 d 0/100 12/100 12/100 0/100 0/100 0/100 0.0003 2,4,5,6,7
0.0% 12% 12% 0.0% 0.0% 0.0%
Belcaro27 2002 657 All subjects: mild leg exercises and hydration recommended 7–8 h 2/179 2/179 4/179 0/179 0/179 0/179 NS 2,3,4,5,6,7,8
1.1% 1.1% 2.2% 0.0% 0.0% 0.0%
Intervention: graduated compression stockings 20–30 mmHg at ankle applied 2–3 h before flight 11–12 h 3/135 0/135 3/135 0/136 0/136 0/136 NS
2.2% 2.2% 2.2% 0.0% 0.0% 0.0%
Cesarone28 2003 282 All subjects: mild leg exercises and hydration recommended 7–8 h 0/72 0/72 0/72 0/72 0/72 0/72 NS 2,3,4,5,6,7,8
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Intervention: graduated compression stockings 14–17 mmHg at ankle applied 3–4 h before flight 11–12 h 2/66 0/66 2/66 0/64 0/64 0/64 NS
3.0% 0.0% 3.0% 0.0% 0.0% 0.0%
Cesarone29 2003 376 All subjects: mild leg exercises and hydration recommended 7–8 h 0/98 0/98 0/98 0/97 0/97 0/97 NS 2,3,4,5,6,7,8
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Intervention: graduated compression stockings 12–18 mmHg at ankle applied 3–4 h before flight 11–12 h 0/71 0/71 0/71 0/75 0/75 0/75 NS
0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Air travelers with DVT risk factors
Belcaro18 2001 833 All subjects: mild leg exercises and hydration recommended 12.4 h 19/422 1/411 <0.001 2,3,5,6,7
Intervention: graduated compression stockings 25 mmHg at ankle applied 6–10 h before flight 4.5% 0.2%
Cesarone30 2002 249 All subjects: mild leg exercises and hydration recommended “Long–haul” 4/82 3/84 NS 4,5,6,7
Intervention: 400 mg ASA daily for 3 d, starting 12 h before flight 4.9% 3.6%
Intervention: enoxaparin 1 mg/kg injected 2–4 h before flight 0/82 NS
0.0%
Belcaro31 2003 205 All subjects: educational video recommending mild leg exercises and hydration 11.8 h 5/102 1/102 6/102 0/103 1/103 1/103 NS 2,3,4,5,6,7
4.9% 1.0% 5.9% 0.0% 1.0% 1.0%
Intervention: graduated compression stockings 14–17 mmHg at ankle applied 3–4 h before flight
Cesarone32 2003 186 All subjects: educational video recommending mild leg exercises and hydration 7.7 h 5/92 0/94 <0.03 2,4,5,6,7
5.4% 0.0%
Intervention: Flite Tabs®
Belcaro33 2004 211 All subjects: educational video recommending mild leg exercises and hydration 8.25 h 1/97 0/101 NS 4,5,6,7
1.0% 0.0%
Intervention: Pycnogenol®

DVT deep venous thrombosis, ASA acetylsalicylic acid.

*All subjects had negative lower extremity ultrasounds prior to travel. All diagnoses of DVT were made by lower extremity ultrasonography performed routinely in all subjects after air travel.

Fisher’s exact test comparing total DVT rates.

See Appendix for explanation of standards.

§Generally, patients with history of DVT, obesity, cancer, coagulation disorders, or “serious” illness were excluded from these studies.

Inclusion criteria generally were history of venous thromboembolism (VTE), obesity, cancer, coagulation disorders, limitation of mobility, and varicose veins. Exclusion criteria generally were severe obesity (weight over 90 kg), clinical disorders requiring anticoagulation, and VTE within 6 months.

Flite Tabs® (Aidan, AZ, USA) contain pinokinase and nattokinase, given 2 capsules 2 hours before flight and 2 capsules 6 hours later, or placebo capsules: Pycnogenol® (Horphag Research Management, Geneva, Switzerland) given 100 mg, 2 capsules 2 hours before flight and 2 capsules 6 hours later and 1 capsule the next day, or placebo capsules.